Active ingredientPefloxacinCat. No. P-P032-001CAS 70458-92-3Family · Pharmaceutical analytical standards
Pefloxacin
A broad-spectrum fluoroquinolone antibiotic, developed in 1979 and approved in France for human use in 1985, used against urinary, genital and gastrointestinal infections. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?It blocks two bacterial enzymes, DNA gyrase and topoisomerase IV, preventing the bacteria from dividing; besides human medicine, it has also been used in veterinary medicine.
Go to the active ingredient →Active ingredientPefloxacinCat. No. P-P032-001CAS 70458-92-3
Active ingredientPefloxacin Mesilate DihydrateCat. No. P-P032-002CAS 149676-40-4
Active ingredientPefloxacin MesylateCat. No. P-P032-003CAS 70458-95-6
Pharmacopoeial impurityPefloxacin EP Impurity BCat. No. P-P032-004CAS 70458-73-0
Pharmacopoeial impurityPefloxacin EP Impurity CCat. No. P-P032-005
Pharmacopoeial impurityPefloxacin EP Impurity DCat. No. P-P032-006CAS 85145-21-7
Pharmacopoeial impurityPefloxacin EP Impurity D TrifluoroacetateCat. No. P-P032-007
Pharmacopoeial impurityPefloxacin EP Impurity ECat. No. P-P032-008CAS 879005-96-6
Pharmacopoeial impurityPefloxacin EP Impurity GCat. No. P-P032-009CAS 70458-94-5No product matches your search.
EDQM standards 4
The official European Pharmacopoeia standards for this family.
ImpurityPefloxacin impurity B CRSEDQM code P0309020Family PefloxacinImpurityPefloxacin impurity C CRSEDQM code P0309030Family PefloxacinReference substancePefloxacin mesilate dihydrate CRSEDQM code P0309000Family PefloxacinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.